139
Views
18
CrossRef citations to date
0
Altmetric
REVIEW ARTICLE

Non-invasive measurement of liver fibrosis: Application of the FibroScan® in hepatology

& , Ph.D , M.D
Pages 85-88 | Published online: 08 Jul 2009

References

  • Poynard T, Ratziu V, Bedossa P. Appropriateness of liver biopsy. Can J Gastroenterol 2000; 14: 543–8
  • Saadeh S, Cammell G, Carey WD, Younossi Z, Barnes D, Easley K. The role of liver biopsy in chronic hepatitis C. Hepatology 2001; 33: 196–200
  • Bravo AA, Sunhil MD, Sheth G, Chopra S. Liver biopsy. N Engl J Med 2001; 344: 495–500
  • Dienstag JL. The role of liver biopsy in chronic hepatitis C. Hepatology 2002; 36: 152–60
  • Gebo KA, Herlong HF, Torbenson MS, Jenckes MW, Chander G, Ghanem KG, et al. Role of liver biopsy in management of chronic hepatitis C: a systematic review. Hepatology 2002; 36: 161–72
  • Bedossa P, Dargère D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003; 37: 1449–57
  • Regev A, Berho M, Jeffers LJ, Milikowski C, Molina EG, Pyrsopoulos NT, et al. Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection. Am J Gastroenterol 2002; 97: 2614–18
  • Colloredo G, Guido M, Sonzogni A, Leandro G. Impact of liver biopsy size on histological evaluation of chronic viral hepatitis: the smaller the sample, the milder the disease. J Hepatol 2003; 39: 239–44
  • Oberti F, Valsesia E, Pilette C, Rousselet MC, Bedossa P, Aubé C, et al. Noninvasive diagnosis of hepatic fibrosis or cirrhosis. Gastroenterology 1997; 113: 1609–16
  • Poynard T, Imbert-Bismut F, Ratziu V, Chevret S, Jardell C, Moussala J, et al. Biochemical markers of liver fibrosis in patients infected by hepatitis C virus: longitudinal validation in a randomized trial. J Viral Hep 2002; 9: 128–33
  • Meyers RP, Ratziu V, Imbert-Bismut F, Charlotte F, Poynard T. Biochemical markers of liver fibrosis: a comparison with historical features in patients with chronic hepatitis C. Am J Gastroenterol 2002; 97: 2419–25
  • Rossi E, Adams L, Prins A, Bulsara M, De Boer B, Garas G, et al. Validation of the FibroTest and biochemical markers score in assessing liver fibrosis in hepatitis C patients. Clin Chem 2003; 49: 450–4
  • Meyers RP, De Torres M, Imbert-Bismut F, Ratziu V, Charlotte F, Poynard T. Biochemical markers of fibrosis in patients with chronic hepatitis C. Dig Dis Sci 2003; 48: 146–53
  • Patel K, Gordon SC, Jacobson I, Hézode C, Oh E, Smith KM, et al. Evaluation of a panel of non-invasive serum markers to differentiate mild from moderate-to-advanced liver fibrosis in chronic hepatitis C patients. J Hepatol 2004; 41: 935–42
  • Poynard T, Imbert-Bismut F, Munteanu M, Messous D, Myers RP, Thabut D, et al. Overview of the diagnostic value of biochemical markers of liver fibrosis (Fibrotest, HCV Fibrosure) and necrosis (ActiTest) in patients with chronic hepatitis C. Comp Hepatol 2004; 3: 8
  • Afdhal NH, Nunes D. Evaluation of liver fibrosis: a concise review. Am J Gastroenterol 2004; 99: 1160–74
  • Poynard T, Munteanu M, Imbert-Bismut F, Charlotte F, Thabut D, Le Calvez S, et al. Prospective analysis of discordant results between biochemical markers and biopsy in patients with chronic hepatitis C. Clin Chem 2004; 50: 1344–55
  • Poynard T, McHutchison J, Manns M, Myers RP, Albrecht J. Biochemical surrogate markers of liver fibrosis and activity in a randomized trial of peginterferon alfa 2b and ribavirin. Hepatology 2003; 37: 481–92
  • Bercoff J, Chaffai S, Tanter M, Sandrin L, Fink M, Gennisson JL, et al. In vivo breast tumor detection using transient elastography. Ultrasound Med Biol 2003; 29: 1387–96
  • Frey H. Realtime elastography. A new ultrasound procedure for the reconstruction of tissue elasticity. Radiologe 2003; 43: 850–5
  • Hiltawsky KM, Kruger M, Starke C, Heuser L, Ermert H, Jensen A. Freehand ultrasound elastography of breast lesion: clinical results. Ultrasound Med Biol 2001; 27: 1461–9
  • El-Gabry EA, Halpern EJ, Strup SE, Gomella LG. Imaging prostate cancer: current and future implications. Oncology 2001;15:325–36; and discussion 339–42.
  • Varghese T, Techavipoo U, Liu W, Zagzebski JA, Chen Q, Frank G, et al. Elastographic measurement of the area and volume of thermal lesions resulting from radiofrequency ablation: pathological correlation. Am J Roentgenol 2003; 181: 701–7
  • Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier S, Mal F, Christidis C, et al. Ultrasound Med Biol 2003; 29: 1705–13
  • Yeh WC, Li PC, Jeng YM, Hsu HC, Kuo PL, Li ML, et al. Elastic modulus measurements of human liver and correlation with pathology. Ultrasound Med Biol 2004; 28: 467–74
  • Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Non-invasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C. Hepatology 2005; 41: 48–54
  • Castera L, Vergniol J, Foucher J, le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastrography, Fibrotest, APRI and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005; 128: 343–50
  • Blanc JF, Bioulac-Sage P, Balabaud C, Desmoulière A. Investigation of liver fibrosis in clinical practice. Hepatology Res 2005. In press.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.